Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Spectral decomposition of human BCL2 bonded to a PROTAC

Journal Article · · The Journal of Chemical Physics
DOI:https://doi.org/10.1063/5.0288378· OSTI ID:3010628
In this study, we have decomposed the linear infrared spectra and two-dimensional infrared spectroscopy of a VHL-recruiting Proteolysis-targeting chimera (PROTAC) complex with BCL-2 to understand the spectral signatures of this complex. Our findings show that both VHL and BCL-2 units have distinct spectral signatures that contribute to the total spectra in different regions. Furthermore, we observed that the interaction between VHL and BCL-2 within the PROTAC complex leads to unique spectral features, indicating a strong synergistic effect. Through detailed analysis, specific bands were identified that correspond to the vibrational modes of the individual components, as well as their interactive modes within the complex. This study provides valuable insight into the molecular interactions within the PROTAC complex, offering a deeper understanding of its structure and function. These insights could be pivotal in designing more efficient PROTACs for targeted protein degradation in therapeutic applications.
Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
3010628
Journal Information:
The Journal of Chemical Physics, Journal Name: The Journal of Chemical Physics Journal Issue: 22 Vol. 163
Country of Publication:
United States
Language:
English

Similar Records

Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC)
Journal Article · Mon Oct 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23107799

Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL
Journal Article · Thu Mar 28 20:00:00 EDT 2024 · Nature Communications · OSTI ID:2470117

FAK-targeting PROTAC demonstrates enhanced antitumor activity against KRAS mutant non-small cell lung cancer
Journal Article · Sun Nov 14 23:00:00 EST 2021 · Experimental Cell Research · OSTI ID:23195449

Related Subjects